Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drug Discovery Today|December 29, 2012
Targeting HIV latency: pharmacologic strategies toward eradicationSifei Xing, Robert F SilicianoThe Journal of Antimicrobial Chemotherapy|September 4, 2013
Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cellsLiang Shan, Sifei Xing, Hung-Chih Yang, et al.Science Translational Medicine|July 15, 2011
A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugsLin Shen, S Alireza Rabi, Ahmad R Sedaghat, et al.The Journal of Antimicrobial Chemotherapy|December 14, 2011
Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activationSifei Xing, Shridhar Bhat, Neeta S Shroff, et al.The Journal of Clinical Investigation|October 7, 2009
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationHung-Chih Yang, Sifei Xing, Liang Shan, et al.Journal of Virology|April 8, 2011
Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activationSifei Xing, Cynthia K Bullen, Neeta S Shroff, et al.Cell Cycle (Georgetown, Tex.)|December 21, 2012
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanismDaniela Boehm, Vincenzo Calvanese, Roy D Dar, et al.The New England Journal of Medicine|June 22, 2007
The HBV drug entecavir - effects on HIV-1 replication and resistanceMoira A McMahon, Benjamin L Jilek, Timothy P Brennan, et al.Immunity|October 19, 2017
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 InfectionLiang Shan, Kai Deng, Hongbo Gao, et al.Plos Pathogens|January 4, 2014
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsCelsa A Spina, Jenny Anderson, Nancie M Archin, et al.Pageof 1